SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-016473
Filing Date
2018-03-12
Accepted
2018-03-12 07:05:08
Documents
4
Period of Report
2018-03-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-7921_18k.htm 8-K 28352
2 EX-10.1 a18-7921_1ex10d1.htm EX-10.1 100005
3 GRAPHIC g79211la01i001.gif GRAPHIC 3077
4 GRAPHIC g79211la01i002.jpg GRAPHIC 3828
  Complete submission text file 0001104659-18-016473.txt   139491
Mailing Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37813 | Film No.: 18681950
SIC: 2834 Pharmaceutical Preparations